Levosulpiride (Compound)

Synonyms:Levosulpiride, 23672-07-3, (S)-(-)-sulpiride, (-)-Sulpiride, Levopraid, S-(-)-Sulpiride, Levobren, Levopride, L-Sulpiride, (S)-sulpiride, lesuride, Levosulpirida, Levosulpiridum, Levosulpiride [INN], N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide, RV-12309, Sulpiride l-form, Sulpiride, (s)-, Sulpiride, (-)-, (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, JTG7R315LK, DTXSID0042583, CHEBI:64119, (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, (S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide, N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide, S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide, Levosulpiride (INN), NCGC00024853-05, Levosulpiridum [INN-Latin], Levosulpirida [INN-Spanish], DTXCID8022583, Nexipride, SMR000466366, CAS-23672-07-3, SULPIRIDE,(+), UNII-JTG7R315LK, C15H23N3O4S, Levogastrol, Sulpiride-l, Sulpiride-S, (S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, BENZAMIDE, 5-(AMINOSULFONYL)-N-(((2S)-1-ETHYL-2-PYRROLIDINYL)METHYL)-2-METHOXY-, Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-, Levopraid (TN), CAS-15676-16-1, MFCD00055220, Tocris-0895, Sulpiride [L-(-)], Biomol-NT_000030, (S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, Levosulpiride (Levogastrol), Lopac0_001089, SCHEMBL70112, GTPL958, MLS000759490, MLS001424014, LEVOSULPIRIDE [MART.], LEVOSULPIRIDE [WHO-DD], SULPIRIDE L-FORM [MI], BPBio1_001221, CHEMBL267044, BDBM81774, HMS2051A08, HMS2089E04, HMS2232P10, HMS3263I20, HMS3266P14, HMS3411D20, HMS3675D20, HMS3884H07, HY-B1059, Tox21_110933, Tox21_501089, HB1836, PDSP1_000516, PDSP1_000620, PDSP1_001649, PDSP2_000514, PDSP2_000616, s2104, AKOS007930553, AKOS015897363, Tox21_110933_1, AC-6821, BCP9000853, CCG-100847, CS-4581, KS-5103, LP01089, NC00097, SDCCGSBI-0051059.P002, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-, NCGC00015966-10, NCGC00016718-01, NCGC00024853-01, NCGC00024853-02, NCGC00024853-03, NCGC00024853-04, NCGC00024853-06, NCGC00024853-09, NCGC00024853-11, NCGC00261774-01, BL166176, BCP0726000072, CAS_15676-16-1, (S)-(-)-Sulpiride, >=98% (titration), EU-0101089, I0821, SW197477-2, D07312, H11356, S 7771, AB00639965-06, AB00639965-08, AB00639965_09, EN300-7390775, A816834, SR-01000076136, SR-01000597436, J-015181, Q1452256, SR-01000076136-2, SR-01000597436-1, BRD-K51671335-001-01-5, BRD-K51671335-001-04-9, (S)-(-)-Sulpiride, VETRANAL(TM), analytical standard, N-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxy-2-sulfamoyl-benzamide, (-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-, 5-HT6 Serotonin Receptor from rat, recombinant, expressed in HEK 293 cells, membrane suspension

Id:688272

Description:nan